COMP <GO>
KIDS vs JNJ // REVENUE GROWTH (YOY)
OrthoPediatrics Corp. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: KIDS 3
— JNJ 7
▲ REVENUE GROWTH (YOY) LEADER: KIDS
LAST: $31.52 (+2.34%) • MKT CAP: $823.0M
revenue-growth
15.40%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
revenue-growth
6.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KIDS VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KIDS | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 73.10% | 67.90% | +5.20 | KIDS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -7.30% | 25.50% | -32.80 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.94% | 2.97% | -4.91 | JNJ | /fcf-yield <GO> |
| Operating Margin | -16.60% | 34.70% | -51.30 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -16.80% | 28.50% | -45.30 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 15.40% | 6.00% | +9.40 | KIDS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.00 | 5.59 | -2.59 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 77.8 | 62.1 | +15.71 | KIDS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $823.0M | $662.49B | -$661.67B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KIDS REV | JNJ REV | KIDS GROSS % | JNJ GROSS % | KIDS FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $236.3M | $94.19B | 73.1% | 67.9% | -$16.0M | $19.70B |
| FY 2024 | $204.7M | $88.82B | 72.6% | 69.1% | -$41.3M | $19.84B |
| FY 2023 | $148.7M | $85.16B | — | — | -$27.0M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KIDS // BETA —
JNJ // BETA 1.08